Some visit links earn us a commission.
Quick verdict
Hims & Hers is the better pick for most patients on overall scoring. Same-day prescription, no lock-in and brand-name confidence. Hims pivoted to branded-only in March 2026 after settling with Novo Nordisk; compounded semaglutide is closed to new patients. Headline price is $299/mo branded Wegovy injectable (self-pay), plus $149/mo membership.
That said, Embla wins on specific dimensions. Embla is the closest thing the US market has to a Noom-meets-Calibrate hybrid that actually leans into the medication. Heavy behavioral coaching, branded-first prescribing, structured 12-month curriculum. Best for buyers who want the program to do half the work.
Side-by-side
| Hims & Hers | Embla | |
|---|---|---|
| Starts from | $299/mo (incl. medication) | $249/mo (+ med separate) |
| Monthly cost gap | Embla is $50/mo cheaper than Hims & Hers | |
| Lock-in | Month-to-month | 12-mo lock-in |
| Time to prescription | 1 day | 7 days |
| Consultation type | Asynchronous | Live |
| Affiliate network | Impact | Impact |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Hims & Hers | Embla | |
|---|---|---|
| Pricing transparency | 6/10 | 4/10 |
| Cancellation terms | 9/10 | 7/10 |
| Onboarding experience | 9/10 | 6/10 |
| Medication options | 5/10 | 7/10 |
| Member reviews | 6/10 | 9.2/10 |
When to choose Hims & Hers
Best for fast async onboarding
Patients who want a fast, low-friction async path to a branded GLP-1 prescription with predictable monthly pricing.
Hims & Hers wins on pricing transparency, cancellation terms, onboarding experience on the dimensional scoring. The caveat: Patients who wanted Hims's old compounded semaglutide tier or who need insurance-routed branded access. Compounded is closed to new patients. Note also: Settled with Novo Nordisk March 9, 2026 over compounded semaglutide marketing
When to choose Embla
Best for structured behavior support
Patients who tried meds-only and bounced, and want a structured behavior program alongside GLP-1.
Embla wins on medication options, member reviews and runs $50/mo cheaper than Hims & Hers at the entry tier ($249 vs $299). Over a year that's $600 you keep. The caveat: Buyers who only want the script and find coaching content patronizing.
If cost is your main filter
Embla is the cheaper monthly: $249 all-in vs $299 for Hims & Hers. That's $50 a month or $600a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $150 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Hims & Hers (month-to-month) and Embla (12-mo lock-in) sit at different cancellation tiers. If you're first-time on a GLP-1 and unsure how you'll tolerate it, Hims & Hers's easier cancellation is the safer trial.
FAQ
Is Hims & Hers cheaper than Embla?
Can I switch from Hims & Hers to Embla mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
